nodes	percent_of_prediction	percent_of_DWPC	metapath
Azatadine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.142	0.185	CbGpPWpGaD
Azatadine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0386	0.0503	CbGpPWpGaD
Azatadine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0378	0.0493	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0324	0.0423	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0318	0.0414	CbGpPWpGaD
Azatadine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0229	0.0298	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.022	0.0287	CbGpPWpGaD
Azatadine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0213	0.0277	CbGpPWpGaD
Azatadine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0206	0.0269	CbGpPWpGaD
Azatadine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0203	0.0264	CbGpPWpGaD
Azatadine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.02	0.0261	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0193	0.0251	CbGpPWpGaD
Azatadine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0187	0.0243	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0179	0.0233	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0173	0.0226	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.017	0.0222	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0168	0.0219	CbGpPWpGaD
Azatadine—Mirtazapine—HRH3—attention deficit hyperactivity disorder	0.0159	0.0685	CrCbGaD
Azatadine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0157	0.0204	CbGpPWpGaD
Azatadine—Mirtazapine—ADRA2C—attention deficit hyperactivity disorder	0.0145	0.0625	CrCbGaD
Azatadine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0131	0.017	CbGpPWpGaD
Azatadine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.011	0.0143	CbGpPWpGaD
Azatadine—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.0107	0.046	CrCbGaD
Azatadine—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.0102	0.0133	CbGpPWpGaD
Azatadine—Loxapine—DRD5—attention deficit hyperactivity disorder	0.009	0.0387	CrCbGaD
Azatadine—Loxapine—ADRA2C—attention deficit hyperactivity disorder	0.00848	0.0365	CrCbGaD
Azatadine—Mirtazapine—DRD4—attention deficit hyperactivity disorder	0.00788	0.0339	CrCbGaD
Azatadine—Clozapine—HRH3—attention deficit hyperactivity disorder	0.00781	0.0336	CrCbGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00745	0.0097	CbGpPWpGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0073	0.00951	CbGpPWpGaD
Azatadine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00724	0.00944	CbGpPWpGaD
Azatadine—Clozapine—ADRA2C—attention deficit hyperactivity disorder	0.00712	0.0306	CrCbGaD
Azatadine—Mirtazapine—DRD3—attention deficit hyperactivity disorder	0.0068	0.0292	CrCbGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00638	0.00831	CbGpPWpGaD
Azatadine—Mirtazapine—SLC6A3—attention deficit hyperactivity disorder	0.00633	0.0272	CrCbGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00625	0.00814	CbGpPWpGaD
Azatadine—Mirtazapine—ADRA2A—attention deficit hyperactivity disorder	0.0062	0.0267	CrCbGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00506	0.00659	CbGpPWpGaD
Azatadine—Mianserin—DRD3—attention deficit hyperactivity disorder	0.005	0.0215	CrCbGaD
Azatadine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00486	0.00633	CbGpPWpGaD
Azatadine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00476	0.0062	CbGpPWpGaD
Azatadine—Mirtazapine—SLC6A4—attention deficit hyperactivity disorder	0.00473	0.0204	CrCbGaD
Azatadine—Mirtazapine—DRD2—attention deficit hyperactivity disorder	0.0047	0.0202	CrCbGaD
Azatadine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00467	0.00608	CbGpPWpGaD
Azatadine—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.00465	0.02	CrCbGaD
Azatadine—Loxapine—DRD4—attention deficit hyperactivity disorder	0.0046	0.0198	CrCbGaD
Azatadine—Cyproheptadine—DRD2—attention deficit hyperactivity disorder	0.00456	0.0196	CrCbGaD
Azatadine—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.00456	0.0196	CrCbGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00442	0.00576	CbGpPWpGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00433	0.00565	CbGpPWpGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00411	0.00535	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00409	0.00533	CbGpPWpGaD
Azatadine—Loxapine—HTR1B—attention deficit hyperactivity disorder	0.00409	0.0176	CrCbGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00398	0.00519	CbGpPWpGaD
Azatadine—Loxapine—DRD3—attention deficit hyperactivity disorder	0.00397	0.0171	CrCbGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00391	0.0051	CbGpPWpGaD
Azatadine—Loxapine—DRD1—attention deficit hyperactivity disorder	0.0039	0.0168	CrCbGaD
Azatadine—Clozapine—DRD4—attention deficit hyperactivity disorder	0.00386	0.0166	CrCbGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00386	0.00503	CbGpPWpGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00379	0.00493	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00372	0.00484	CbGpPWpGaD
Azatadine—Loxapine—SLC6A3—attention deficit hyperactivity disorder	0.00369	0.0159	CrCbGaD
Azatadine—Mirtazapine—HTR2A—attention deficit hyperactivity disorder	0.00364	0.0156	CrCbGaD
Azatadine—Loxapine—ADRA2A—attention deficit hyperactivity disorder	0.00362	0.0156	CrCbGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0036	0.00469	CbGpPWpGaD
Azatadine—Cyproheptadine—HTR2A—attention deficit hyperactivity disorder	0.00353	0.0152	CrCbGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00352	0.00459	CbGpPWpGaD
Azatadine—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.00348	0.015	CrCbGaD
Azatadine—Mianserin—DRD2—attention deficit hyperactivity disorder	0.00346	0.0149	CrCbGaD
Azatadine—Clozapine—HTR1B—attention deficit hyperactivity disorder	0.00343	0.0148	CrCbGaD
Azatadine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	0.00342	0.0147	CrCbGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00341	0.00444	CbGpPWpGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00335	0.00437	CbGpPWpGaD
Azatadine—Clozapine—DRD3—attention deficit hyperactivity disorder	0.00333	0.0143	CrCbGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00331	0.00431	CbGpPWpGaD
Azatadine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.0033	0.0043	CbGpPWpGaD
Azatadine—Clozapine—DRD1—attention deficit hyperactivity disorder	0.00327	0.0141	CrCbGaD
Azatadine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00326	0.00425	CbGpPWpGaD
Azatadine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.00319	0.0137	CrCbGaD
Azatadine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00313	0.00408	CbGpPWpGaD
Azatadine—Nortriptyline—SLC6A4—attention deficit hyperactivity disorder	0.00311	0.0134	CrCbGaD
Azatadine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.0031	0.0133	CrCbGaD
Azatadine—Nortriptyline—DRD2—attention deficit hyperactivity disorder	0.00309	0.0133	CrCbGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00308	0.00402	CbGpPWpGaD
Azatadine—Clozapine—ADRA2A—attention deficit hyperactivity disorder	0.00304	0.0131	CrCbGaD
Azatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00292	0.0038	CbGpPWpGaD
Azatadine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00288	0.00376	CbGpPWpGaD
Azatadine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	0.00283	0.0122	CrCbGaD
Azatadine—Loxapine—SLC6A4—attention deficit hyperactivity disorder	0.00276	0.0119	CrCbGaD
Azatadine—Loxapine—DRD2—attention deficit hyperactivity disorder	0.00275	0.0118	CrCbGaD
Azatadine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00275	0.00358	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00269	0.0035	CbGpPWpGaD
Azatadine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00268	0.00349	CbGpPWpGaD
Azatadine—Mianserin—HTR2A—attention deficit hyperactivity disorder	0.00267	0.0115	CrCbGaD
Azatadine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0026	0.00338	CbGpPWpGaD
Azatadine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	0.00256	0.011	CrCbGaD
Azatadine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00255	0.00333	CbGpPWpGaD
Azatadine—Desipramine—DRD2—attention deficit hyperactivity disorder	0.00254	0.0109	CrCbGaD
Azatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00252	0.00328	CbGpPWpGaD
Azatadine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00252	0.00328	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00249	0.00325	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00244	0.00318	CbGpPWpGaD
Azatadine—Nortriptyline—HTR2A—attention deficit hyperactivity disorder	0.00239	0.0103	CrCbGaD
Azatadine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00235	0.00306	CbGpPWpGaD
Azatadine—Clozapine—DRD2—attention deficit hyperactivity disorder	0.00231	0.00992	CrCbGaD
Azatadine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0022	0.00286	CbGpPWpGaD
Azatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00216	0.00281	CbGpPWpGaD
Azatadine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	0.00216	0.00928	CrCbGaD
Azatadine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	0.00214	0.00923	CrCbGaD
Azatadine—Loxapine—HTR2A—attention deficit hyperactivity disorder	0.00212	0.00913	CrCbGaD
Azatadine—Desipramine—HTR2A—attention deficit hyperactivity disorder	0.00197	0.00846	CrCbGaD
Azatadine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00186	0.00243	CbGpPWpGaD
Azatadine—Clozapine—HTR2A—attention deficit hyperactivity disorder	0.00178	0.00767	CrCbGaD
Azatadine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00171	0.00223	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00169	0.00221	CbGpPWpGaD
Azatadine—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00167	0.00218	CbGpPWpGaD
Azatadine—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00166	0.00216	CbGpPWpGaD
Azatadine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	0.00166	0.00713	CrCbGaD
Azatadine—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00165	0.00215	CbGpPWpGaD
Azatadine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00164	0.00214	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00163	0.00212	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00152	0.00197	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00148	0.00193	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00147	0.00192	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00147	0.00191	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00144	0.00188	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00144	0.00188	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00142	0.00186	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00142	0.00184	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00138	0.00179	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00133	0.00174	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00133	0.00173	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00131	0.00171	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00129	0.00169	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00121	0.00157	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.001	0.0013	CbGpPWpGaD
Azatadine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00093	0.00121	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000874	0.00114	CbGpPWpGaD
Azatadine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000844	0.0011	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000813	0.00106	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000787	0.00103	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000774	0.00101	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000764	0.000996	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000712	0.000928	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000684	0.000892	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000499	0.00065	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000472	0.000615	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000472	0.000615	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000465	0.000605	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000432	0.000563	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000378	0.000492	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000359	0.000468	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000286	0.000373	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000284	0.00037	CbGpPWpGaD
Azatadine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000264	0.000344	CbGpPWpGaD
Azatadine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000123	0.00016	CbGpPWpGaD
